drugset / Trial / NCT05845502
Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma
Terminated
8 enrolled
Shantou University Medical College
Guangdong ProCapZoom Biosciences Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ003 in the treatment of advanced hepatocellular carcinoma.
Timeline
- Start
- 2021-07-26
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
Outcome
Outcome not reported
Stopped (Enrollment): “Failed to recruit more volunteers”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SZ003 CAR-NK | Cell therapy | 5e+06 cells | Other |
| Subject | SZ003 CAR-NK | Cell therapy | 1e+08 cells | Other |
| Subject | SZ003 CAR-NK | Cell therapy | 2e+08 cells | Other |
| Subject | SZ003 CAR-NK | Cell therapy | 5e+08 cells | Other |